RxDoctor Payments Data

Karin Gerberding

Women's Health · Liberty, MONPI 1265849335

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.

$2,356in general payments, 2019–2025

Across 125 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$495
  • Organon$268
  • Mayne Pharma Commercial LLC$205
  • Pfizer$179
  • Sumitomo Pharma America, Inc.$167
  • Astellas Pharma US Inc$144
  • plus $900 from 18 others

What the payments were for

  • Food & beverage$2,31198%
  • Education$452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,356 in reported general payments places this provider in the 85th percentile of 208 women's health providers in Missouri.

See all women's health providers in Missouri

Medicare billing

Part B allowed, 2024
$11,226
Medicare patients
45
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate12$1,013
Estradiol31$984
Norethindron-Ethinyl EstradiolNorethindrone Ac/Eth Estradiol16$406
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$92

Paid to pharmacies, not to this prescriber.

Other women's health in Liberty

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →